Answers are grounded in this paper and cite their sources.
Demonstrates increased cytotoxicity in folate receptor-expressing cancer cells, suggesting improved treatment potential.
We developed conjugates between monoclonal antibody (mAb) and folic acid (FA) by using a tryptophan (Trp)-selective reaction, which yields relatively homogenous products compared to conventional methods. The obtained mAb-FA conjugates showed significant cellular cytotoxicity toward folate receptor-expressing cancer cells, demonstrating that the conjugates retained the Fc region's original function.
No takes yet. Share an insight, caveat, or question.
Tagawa et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: